Please be aware that stock which was originally intended for supply in New Zealand will be distributed in Australia to avoid a disruption in supply of OxyNorm® injection. This will be the case until appropriately packaged product is available for importation in Australia. This applies to OXYNORM® 50MG/1ML solution for infusion ampoule (oxycodone hydrochloride) – batch […]
For the second consecutive year, Mundipharma Pty Limited (Mundipharma) has been awarded “Specialised Ethical Supplier of the Year” at the Annual Sigma Customer Awards.
The Award was received early November by Mundipharma’s Logistics and Supply Chain team in front of over 300 guests from across the industry.
Robert Ingui, Finance and Operations director at Mundipharma said: “It is […]
Science Meets Nature To Deliver a New Range of First Aid Treatments
Wound Awareness Week – 16-21 October
As a leader in melaleuca oil production, Australia is enabling the development of the next generation of family first-aid treatments. Harnessing the antiseptic healing properties of melaleuca oil, researchers have created a new range of natural, first-aid treatments to […]
Leading nurse practitioner Sue McDonald was selected as the winner of the 2016 Australian College of Nurse Practitioners (ACNP) Quality Use of Medicines Award in Alice Springs on September 2nd.
Each year, the ACNP recognises a Nurse Practitioner/Advanced Practice Nurse who works consistently with consumers with moderate or severe pain to optimise their health and wellbeing. […]
Mundipharma Pty Limited (MPL) are proud to announce the renewal of their partnership with leading child protection charity, Barnardos Australia.
In 2014, MPL and Barnardos formed a strategic alliance aimed at improving the lives of both parents and children through their participation in an early intervention program called Parents As Teachers (PAT).
Piloted in the small town […]
Leading consultant pharmacists Neil Petrie and Ingrid Johnston have won the 2016 Pharmaceutical Society of Australia (PSA) Award for Quality Use of Medicines (QUM) in Pain Management. As the peak national body for pharmacists, PSA has partnered with Mundipharma to offer the 2016 QUM Award to highlight and support pharmacists’ role in pain management. PSA and Mundipharma […]
Mundipharma Pty Limited (Mundipharma) is proud to announce that they have been selected as finalists of the Best Leadership Development Program and Best Change Management Strategy categories at the prestigious Australian HR Awards which they entered this year for the first time.
These awards bring together industry leaders to celebrate excellence in the HR profession, recognising […]
Mundipharma Pty Limited rolls out first of its kind aged care initiative with Catholic Healthcare.
45–93% of residents in aged care facilities have chronic pain (1,2), but research has also shown that there is a disconnect between the nursing record of pain and the residents’ reporting of pain (1,3). The PANACEA™ (Pain Advocacy Nurse in Aged […]
Raising awareness around the correct first aid treatment for minor burns.
National Burns Awareness Month will be held for the first time in June 2016, to provide awareness around the correct first aid treatment for minor burns. It is being led by the Julian Burton Burns Trust, Australia’s leading community organisation dedicated to burn injury, with the support of […]
Please be aware that Dilaudid-HP injection 500mg/50mL vial will be discontinued as of 31 August 2016.
Dilaudid injection (ampoules 2mg/1mL); and Dilaudid-HP injection (ampoule 10mg/1mL and 50mg/5mL) remain available.
Full information about our products, including the PIs and CMIs are available here.
® DILAUDID is a registered trade mark